RS2119690 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (15)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| HDL cholesterol levels | A | OR: 0.15 | 2E-79 | PubMed |
| Total concentration of lipoprotein particles (UKB data field 23427) | A | β: 0.076 | 4E-54 | PubMed |
| Triglyceride levels | A | OR: 0.12 | 2E-45 | PubMed |
| HDL x low social support interaction (2df test) | A | β: 0.002 | 1E-44 | PubMed |
| Metabolic syndrome | G | OR: 0.16 | 4E-33 | PubMed |
| Cholesterol levels in small HDL | G | β: 0.052 | 7E-30 | PubMed |
| APOC1 protein levels | A | β: 0.062 | 1E-25 | PubMed |
| Medication use (HMG CoA reductase inhibitors) | A | β: 0.058 | 1E-20 | PubMed |
| Cholesterol to total lipids ratio in small LDL | G | β: 0.037 | 4E-16 | PubMed |
| Heart failure (MTAG) | G | OR: 7.22 | 5E-13 | PubMed |
| 1-(1-enyl-palmitoyl)-2-linoleoyl-GPC (P-16:0/18:2) levels | A | β: 0.074 | 3E-11 | PubMed |
| 1-(1-enyl-stearoyl)-2-linoleoyl-GPC (p-18:0/18:2) levels | A | β: 0.074 | 1E-10 | PubMed |
| Creatinine levels | G | β: 0.024 | 8E-10 | PubMed |
| Waist-hip ratio | — | — | 3E-9 | PubMed |
| Waist-to-hip ratio adjusted for BMI | — | — | 2E-8 | PubMed |